Efficacy Study of Polyethylene Glycol 3350-electrolyte Solution (GoLYTELY®) Versus Lactulose in Patients With Hepatic Encephalopathy.



Status:Archived
Conditions:Infectious Disease, Neurology, Psychiatric, Gastrointestinal
Therapuetic Areas:Gastroenterology, Immunology / Infectious Diseases, Neurology, Psychiatry / Psychology
Healthy:No
Age Range:Any
Updated:7/1/2011
Start Date:January 2011
End Date:January 2013

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

Randomized Controlled Trial Evaluating the Efficacy of Polyethylene Glycol 3350-electrolyte Solution (GoLYTELY®) in Patients With Hepatic Encephalopathy.


This study is being done to find out if the laxative polyethylene glycol (also known as
GoLYTELY® or Miralax®) can treat your hepatic encephalopathy (confusion due to your liver
disease and/or cirrhosis) better and/or more safely than lactulose (another laxative). In
this study, the investigators will evaluate if polyethylene glycol (GoLYTELY®) is more
effective than lactulose on neurocognition (memory and thinking skills) and determine if it
decreases the hospital stay.



We found this trial at
1
site
UT Soutwestern Medical Center at Dallas
5303 Harry Hines Boulevard
Dallas, Texas 75390
(214) 648-3111
UT Soutwestern Medical Center at Dallas UT Southwestern Medical Center is distinctive for its overall...
?
mi
from
Dallas, TX
Click here to add this to my saved trials